One-year hospital pharmacy residencies retain eligibility for special Medicare payment.
D000970:Antineoplastic Agents / Q000191:economics; D014487:Centers for Medicare and Medicaid Services, U.S. / Q000331:legislation & jurisprudence; D004512:Education, Pharmacy / Q000331:legislation & jurisprudence*; D007376:Interleukin-2 / Q000031:analogs & derivatives* / Q000191:economics; D007397:Internship, Nonmedical / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000331:legislation & jurisprudence*; D011994:Recombinant Proteins / Q000191:economics; D014481:United States
D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; C082598:aldesleukin